
May 2022, Vol 140, No. 5, Pages 452-549
Viewpoint
1. Elevating Social Determinants of Health and Community Engagement in Eye Care—The Time Is Now
- Angela R. Elam, MD; Kristen H. Nwanyanwu, MD, MBA, MHS; Adrienne W. Scott, MD
- JAMA Ophthalmol. 2022;140(5):453-454. doi:10.1001/jamaophthalmol.2022.0409
- PDF
Editorial
2. JAMA Ophthalmology—The Year in Review, 2021Fact and Opinion
- Neil M. Bressler, MD
- JAMA Ophthalmol. 2022;140(5):455-457. doi:10.1001/jamaophthalmol.2022.0441
- PDF
Original Investigation
3. Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein OcclusionStudy of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18
- Ingrid U. Scott, MD, MPH; Neal L. Oden, PhD; Paul C. VanVeldhuisen, PhD; et al.
- JAMA Ophthalmol. 2022;140(5):458-464. doi:10.1001/jamaophthalmol.2022.0352
- PDF
4. Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era
- Kellyn N. Bellsmith, MD; Michael J. Gale, MD; Sen Yang, BS; et al.
- JAMA Ophthalmol. 2022;140(5):465-471. doi:10.1001/jamaophthalmol.2022.0396
- PDF
5. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle LensesA Randomized Clinical Trial
- Jinhua Bao, PhD; Yingying Huang, MD; Xue Li, PhD; et al.
- JAMA Ophthalmol. 2022;140(5):472-478. doi:10.1001/jamaophthalmol.2022.0401
- PDF
6. Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US
- Mahyar Etminan, PharmD, MSc; Mohit Sodhi, MSc; Frederick S. Mikelberg, MD; et al.
- JAMA Ophthalmol. 2022;140(5):480-484. doi:10.1001/jamaophthalmol.2022.0663
- PDF
7. Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting DiabetesA Systematic Review and Meta-analysis
- Felicia Widyaputri, MD, PhD; Sophie L. Rogers, MEpi; Rathika Kandasamy, MD; et al.
- JAMA Ophthalmol. 2022;140(5):486-494. doi:10.1001/jamaophthalmol.2022.0050
- PDF
8. Association Between Social Determinants of Health and Retinopathy of Prematurity Outcomes
- Reem Karmouta, BS; Marie Altendahl, BA; Tahmineh Romero, MS; et al.
- JAMA Ophthalmol. 2022;140(5):496-502. doi:10.1001/jamaophthalmol.2022.0667
- PDF
9. Rates of Visual Field Change in Patients With Glaucoma and Healthy IndividualsFindings From a Median 25-Year Follow-up
- Sara Giammaria, MD; Donna M. Hutchison, BSc; Paul E. Rafuse, MD, PhD; et al.
- JAMA Ophthalmol. 2022;140(5):504-511. doi:10.1001/jamaophthalmol.2022.0671
- PDF
10. Economic Evaluation of the Merit-Based Incentive Payment System for OphthalmologistsAnalysis of 2019 Quality Payment Program Data
- Sean T. Berkowitz, MD, MBA; Jonathan Siktberg, BBA; Arulita Gupta, BS; et al.
- JAMA Ophthalmol. 2022;140(5):512-518. doi:10.1001/jamaophthalmol.2022.0798
- PDF
Brief Report
11. Sex Differences in Salaries of Academic Ophthalmologists in the United States
- Parisa Emami-Naeini, MD, MPH; Monica K. Lieng, PhD; Jenny Chen, MD, MS
- JAMA Ophthalmol. 2022;140(5):519-522. doi:10.1001/jamaophthalmol.2022.0376
- PDF
12. Changes in the Incidence of Retinal Vascular Occlusions After COVID-19 Diagnosis
- Bobeck S. Modjtahedi, MD; Duy Do, PhD; Tiffany Q. Luong, MPH; et al.
- JAMA Ophthalmol. 2022;140(5):523-527. doi:10.1001/jamaophthalmol.2022.0632
- PDF
13. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy
- Elana Meer, BA; J. Clay Bavinger, MD; Yinxi Yu, MS; et al.
- JAMA Ophthalmol. 2022;140(5):529-532. doi:10.1001/jamaophthalmol.2022.0633
- PDF
Invited Commentary
14. Valid but Undervalued
- Ji-Peng Olivia Li, MA, FRCOphth; Pearse A. Keane, FRCOphth, PhD; Peter Thomas, FRCOphth, PhD
- JAMA Ophthalmol. 2022;140(5):471. doi:10.1001/jamaophthalmol.2022.0549
- PDF
15. Clinical Relevance of Myopia Control With Specialized Spectacles
- David C. Musch, PhD, MPH; Steven M. Archer, MD
- JAMA Ophthalmol. 2022;140(5):478-479. doi:10.1001/jamaophthalmol.2022.0533
- PDF
16. Phase 4 Studies on Phosphodiesterase 5 Inhibitors
- Brian L. VanderBeek, MD, MPH, MSCE; Maureen G. Maguire, PhD
- JAMA Ophthalmol. 2022;140(5):484-485. doi:10.1001/jamaophthalmol.2022.0664
- PDF
17. Diabetic Retinopathy in Pregnancy
- Janet S. Sunness, MD; Sidney A. Schechet, MD
- JAMA Ophthalmol. 2022;140(5):495. doi:10.1001/jamaophthalmol.2022.0051
- PDF
18. Bridging the Gap—Untangling Race, Ethnicity, and Social Determinants of Health as Risk Factors for Retinopathy of Prematurity
- Alejandra G. de Alba Campomanes, MD, MPH
- JAMA Ophthalmol. 2022;140(5):502-503. doi:10.1001/jamaophthalmol.2022.0668
- PDF
19. COVID-19 Diagnosis and Incidence of Retinal Thromboembolism
- K. Thiran Jayasundera, MD, MS; Rebhi O. Abuzaitoun, MD; David C. Musch, PhD, MPH
- JAMA Ophthalmol. 2022;140(5):527-528. doi:10.1001/jamaophthalmol.2022.0666
- PDF
20. Use of Fenofibrate in the Management of Diabetic Retinopathy—Large Population Analyses
- Robert N. Frank, MD
- JAMA Ophthalmol. 2022;140(5):533. doi:10.1001/jamaophthalmol.2022.0634
- PDF
JAMA Ophthalmology Clinical Challenge
21. Large Subconjunctival Mass in a Patient With a History of Multiple Previous Ocular Surgeries
- Dmytro Pavlenko, MD; Faith A. Birnbaum, MD; Teresa C. Chen, MD
- JAMA Ophthalmol. 2022;140(5):534-535. doi:10.1001/jamaophthalmol.2021.5262
- PDF
22. Papilledema in an Adolescent With Anemia and Leukopenia
- Aaron Priluck, MD; Andrew Carey, MD
- JAMA Ophthalmol. 2022;140(5):536-537. doi:10.1001/jamaophthalmol.2021.5310
- PDF
23. Ptosis With Fluctuating Diplopia
- Jin Kyun Oh, MD; Roman Shinder, MD; Nickisa M. Hodgson, MD, MAS
- JAMA Ophthalmol. 2022;140(5):538-539. doi:10.1001/jamaophthalmol.2021.5629
- PDF
24. Unilateral Yellowish Eye in a Woman With an Intraocular Mass
- Leonardo Lando, MD; Filiberto Altomare, MD; Hatem Krema, MD, MSc
- JAMA Ophthalmol. 2022;140(5):540-541. doi:10.1001/jamaophthalmol.2021.5683
- PDF
Observation
25. Familial Glaucoma—A Pedigree Revisited With Genetic Testing After 70 Years
- Harry A. Quigley, MD; Edwin M. Stone, MD, PhD; John H. Fingert, MD, PhD
- JAMA Ophthalmol. 2022;140(5):543-544. doi:10.1001/jamaophthalmol.2022.0556
- PDF
26. Penetrating Orbital Injury Due to a Wooden Dowel in a Birthday Cake
- Marissa K. Shoji, MD; Michelle M. Maeng, MD; David T. Tse, MD
- JAMA Ophthalmol. 2022;140(5):544-546. doi:10.1001/jamaophthalmol.2022.0788
- PDF
Ophthalmic Images
27. Skin Extravasation After Fluorescein Angiography in an Adult Man With Waldenström Macroglobulinemia
- Asaf Shemer, MD; Naomi Rahimi-Levene, MD, MHA; Nadav Shoshany, MD
- JAMA Ophthalmol. 2022;140(5):e220009. doi:10.1001/jamaophthalmol.2022.0009
- PDF
28. Unusual Basal Cell Carcinoma in an Adult Woman With Gorlin-Goltz Syndrome
- Cam Loveridge-Easther, MBChB; Robert Weatherhead, MBChB
- JAMA Ophthalmol. 2022;140(5):e220637. doi:10.1001/jamaophthalmol.2022.0637
- PDF
Comment & Response
29. Association of Public Health Measures During the COVID-19 Pandemic With the Incidence of Infectious Conjunctivitis
- Justin T. Bradshaw, BS; Lawsen M. Parker, BS; Jeffrey P. Gardiner, DO
- JAMA Ophthalmol. 2022;140(5):546-547. doi:10.1001/jamaophthalmol.2022.0279
- PDF
30. Association of Public Health Measures During the COVID-19 Pandemic With the Incidence of Infectious Conjunctivitis—Reply
- Thomas M. Meirick, MD; Juan Lavista Ferres, MSc; Aaron Y. Lee, MD, MSCI
- JAMA Ophthalmol. 2022;140(5):547-548. doi:10.1001/jamaophthalmol.2022.0282
- PDF
31. Outcome of COVID-19–Associated Rhino-Orbital Mucormycosis
- Ritu Arora, MD, DNB; Ruchi Goel, MS, DNB; Ravi Meher, MS
- JAMA Ophthalmol. 2022;140(5):548. doi:10.1001/jamaophthalmol.2022.0618
- PDF
32. Outcome of COVID-19–Associated Rhino-Orbital Mucormycosis—Reply
- Purva S. Date, DNB; Twinkle Choksi, MD; Avinash B. Ingole, MS
- JAMA Ophthalmol. 2022;140(5):548-549. doi:10.1001/jamaophthalmol.2022.0617
- PDF
Peer Reviewers List
33. JAMA Ophthalmology Peer Reviewers in 2021
- JAMA Ophthalmol. 2022;140(5):e220186. doi:10.1001/jamaophthalmol.2022.0186
- PDF
JAMA Ophthalmology Masthead
34. JAMA Ophthalmology
- JAMA Ophthalmol. 2022;140(5):452. doi:10.1001/jamaophthalmol.2021.4243
- PDF